CEL-SCI CORPORATION Current Liabilities
CEL-SCI CORPORATION (CVM) had Current Liabilities of $5.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $5.08M.
- 2026-03-31: Liabilities, Current $4.81M.
- 2025-12-31: Liabilities, Current $5.04M.
- 2025-09-30: Liabilities, Current $5.13M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.08M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.81M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.04M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $5.13M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $5.62M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $5.50M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $5.48M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $4.62M 10-K · filed 2025-12-29 | |
| 2024-06-30 | $5.51M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $5.09M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.87M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $5.59M 10-K · filed 2025-01-13 | |
| 2023-06-30 | $5.29M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $5.31M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $4.74M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $4.66M 10-K · filed 2023-12-21 | |
| 2022-06-30 | $4.02M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $4.47M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.33M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $3.94M 10-K · filed 2022-12-27 | |
| 2021-06-30 | $5.16M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $5.82M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $7.33M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $4.27M 10-K · filed 2021-12-21 | |
| 2020-06-30 | $4.65M 10-Q/A · filed 2020-12-31 | |
| 2020-03-31 | $5.27M 10-Q/A · filed 2020-12-30 | |
| 2019-12-31 | $4.57M 10-Q/A · filed 2020-12-30 | |
| 2019-09-30 | $3.02M 10-Q/A · filed 2020-12-31 | |
| 2019-06-30 | $4.23M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.47M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $5.89M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $9.23M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $8.38M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $10.86M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $10.60M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $10.84M 10-K · filed 2018-12-19 | |
| 2017-06-30 | $10.24M 10-Q/A · filed 2017-12-11 | |
| 2017-03-31 | $8.41M 10-Q/A · filed 2017-12-11 | |
| 2016-12-31 | $3.79M 10-Q/A · filed 2017-12-11 | |
| 2016-09-30 | $4.01M 10-K · filed 2017-12-29 | |
| 2016-06-30 | $5.28M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.09M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $5.68M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $6.71M 10-K/A · filed 2017-12-11 | $6.85M 10-K · filed 2015-12-11 |
| 2015-06-30 | $5.27M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $3.68M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $3.79M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $3.15M 10-K · filed 2015-12-11 | |
| 2014-06-30 | $3.33M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $3.32M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.38M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $3.55M 10-K · filed 2014-12-23 | |
| 2013-06-30 | $2.97M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $1.88M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.78M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $1.91M 10-K · filed 2013-12-27 | |
| 2012-06-30 | $2.03M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $2.03M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.95M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $7.22M 10-K · filed 2012-12-14 | |
| 2011-06-30 | $11.02M 10-Q · filed 2011-08-09 | |
| 2010-09-30 | $3.30M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |